Time to initiation of neo‐adjuvant chemotherapy for breast cancer treatment does not influence patient survival: A study of US breast cancer patients-Reference-Cited by-同舟云学术

Time to initiation of neo‐adjuvant chemotherapy for breast cancer treatment does not influence patient survival: A study of US breast cancer patients

Published:2019-09-12 Issue:4 Volume:26 Page:625-629
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast J

Author:

Livingston‐Rosanoff Devon¹²,Hanlon Bret²,Marka Nicholas²,Vande Walle Kara¹²,Stankowski‐Drengler Trista¹²,Schumacher Jessica²,Greenberg Caprice C.¹²,Neuman Heather¹²,Wilke Lee G.¹

Affiliation:

1. Division of Surgical Oncology Department of Surgery University of Wisconsin Madison WI

2. Department of Surgery Wisconsin Institute for Surgical Outcomes Research University of Wisconsin Madison WI

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tbj.13625

Reference21 articles.

1. Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer

2. Guidelines insights. Breast cancer, Version 1.2017. Featured updates to the NCCN guidelines;Gradishar W;Jnccn,2017

3. Neoadjuvant Chemotherapy Use in Breast Cancer is Greatest in Excellent Responders: Triple-Negative and HER2+ Subtypes

4. Neoadjuvant chemotherapy in non‐metastatic breast cancer: a study on practice trends in a regional cancer treatment service

5. Comparison of the prognostic significance of Chevallier and Sataloff's pathologic classifications after neoadjuvant chemotherapy of operable breast cancer

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathological complete response of locally advanced triple-negative breast cancer: case report;Siberian journal of oncology;2024-09-10

2. Clinical impact of delaying initiation of adjuvant chemotherapy in patients with early triple negative breast cancer;Breast Cancer Research and Treatment;2024-01-19

3. Does timing of neoadjuvant chemotherapy influence the prognosis in patients with early triple negative breast cancer?;Journal of Cancer Research and Clinical Oncology;2023-07-07

4. Does timing of neoadjuvant chemotherapy influence the prognosis in patients with early triple negative breast cancer?;2023-06-09

5. Outcomes of a Multidisciplinary Team in the Management of Patients with Early-Stage Breast Cancer Undergoing Neoadjuvant Chemotherapy at a Community Cancer Center;Current Oncology;2023-05-08